Evidence map›Paper›PMID 41469806›Full record

ReviewDermatologie (Heidelberg, Germany)2026

[Treatments with neuromodulators : Anatomical principles, mechanisms of action, and safe utilization in aesthetic medicine].

Sebastian Cotofana, Michael Alfertshofer

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Dermatologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sebastian CotofanaDepartment of Plastic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA. scotofana24@gmail.com.
Michael AlfertshoferDepartment of Oral and Maxillofacial Surgery, Charité University Hospital Berlin, Berlin, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeuromodulator treatments are widely accepted, highly popular and represent a hallmark of every aesthetic-oriented minimally invasive practice. Despite its limited adverse events profile, some unexpected negative clinical outcomes have been reported.

objectiveThe goal of this work is to better understand the relationship between underlying anatomy and the occurrence of adverse events.

methodsThis article is designed as a narrative anatomic review summarizing the current anatomic literature and comparing it to the most frequently observed adverse events following treatment with neuromodulators.

resultsEyebrow ptosis occurs most frequently when the injections are performed too far caudal, whereas eyelid ptosis can occur when the product is injected too deep. Asymmetric lip position can occur when the risorius or the depressor labii inferioris muscle are inadvertently targeted. Difficulties during swallowing or head anteflexion is most likely related to the administration of product into the deep layers of the neck (instead of the subdermal layer), thereby affecting the muscles deep to the platysma.

conclusionKnowledge of the three-dimensional facial anatomy is crucial when it comes to treatment with neuromodulators and should replace the previous concepts of two dimensions. Knowing that facial muscles are three- and not two-dimensional will guide practitioners toward safer procedures with less collateral damage and an increased safety profile when reducing facial rhytids with neuromodulators.

Indexed as

Facial musclesPtosisThree-dimensional anatomyToxin treatmentsWrinkle reduction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.